Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
United States
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio Last updated February 2026